| Metric | Q2'25 | Q3'25 | Change |
|---|---|---|---|
| Production (Bcfe) | Q2: 596 (flat YoY) | Q3: Near high end of guidance despite curtailments | Strategic volume management |
| Free Cash Flow Attributable to EQT | Q2: $240M ($375M ex-legal) | Q3: $484M ($505M ex-Olympus costs) | +102% sequential improvement |
| Net Debt | Q2: $7.8B | Q3: Just under $8B despite $600M outflows | Better than expected |
| Corporate Differential | Q2: As guided | Q3: $0.12 tighter than midpoint | Marketing outperformance |
| Capital Spending | Q2: $50M below low end | Q3: $70M below midpoint | Accelerating efficiency gains |
| Total Cash Cost per Unit | Q2: Not specified | Q3: Record low | New efficiency record |
| Olympus Integration Timeline | N/A | 34 days (fastest in EQT history) | Execution excellence |
| MVP Boost Capacity | Initial: 500k Dth/d | Upsized: 600k+ Dth/d | +20% expansion |
| Strategic Curtailments | Q2: Minimal | Q4 Guide: 15-20 Bcfe in October | Active volume management |
| Base Dividend | Q2: $0.63 annualized | Q3: $0.66 annualized | +5% increase |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.